Abstract
A PtIV prodrug bearing a vascular disrupting agent demonstrates antiangiogenic and antimetastatic potentialities against metastatic triple-negative breast cancer cells.
Funding Information
  • National Natural Science Foundation of China (31570809, 21877059, 21731004)
  • Natural Science Foundation of Jiangsu Province (BK20150054)
  • National Basic Research Program of China (2015CB856300)

This publication has 31 references indexed in Scilit: